Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research from University of Munich yields new findings on breast cancer
July 3rd, 2008
According to recent research from Munich, Germany, "The dietary antioxidant Curcumin has been proposed for cancer chemoprevention since it induces apoptosis and inhibits the formation of breast cancer metastases. Curcumin acts through the inhibition of phosphorylation of the inhibitor of kappa B (I kappa B), which in turn reduces the nuclear translocation of nuclear factor kappa B (NF kappa B), an inflammation- and cell survival-related transcription factor." "However, it is not clear whether the strong antimetastatic effect can exclusively be explained by inhibition of NF kappa B. Here, we addressed the effects of Curcumin (IC50 = 17 mc M) in MDA-MB-231 breast cancer...
Source: Women's Health Weekly (2008-07-03)
|
